Table 3.

Scaled up program pathways by outcomes

Outcome	Type I Comprehensive % (N)	Type II Efficacy omitter % (N)	Type III Trial omitter % (N)	Type IV At scale dissemination % (N)	Total (all programs) % (N)
Institutionalised	36.4 (8)	0.0 (0)	50.0 (5)	66.7 (4)	42.5 (17)
Institutionalised & Adapted	13.6 (3)	50.0 (1)	0.0 (0)	0.0 (0)	10.0 (4)
Institutionalised & Commercialised	4.5 (1)	0.0 (0)	0.0 (0)	0.0 (0)	2.5 (1)
Commercialised	22.7 (5)	0.0 (0)	20.0 (2)	16.7 (1)	20.0 (8)
Adapted	9.1 (2)	0.0 (0)	0.0 (0)	0.0 (0)	5.0 (2)
Unknown	13.6 (3)	50.0 (1)	30.0 (3)	16.7 (1)	20.0 (8)
Total	100.0 (22)	100.0 (2)	100.0 (10)	100.0 (6)	100.0 (40)